TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC: Safety Overview
| Metric | TALAZOPARIB | TALIMOGENE LAHERPAREPVEC |
|---|---|---|
| Total FAERS Reports | 1,477 | 1,475 |
| Deaths Reported | 278 | 164 |
| Death Rate | 18.8% | 11.1% |
| Hospitalizations | 553 | 286 |
| Average Patient Age | 60.1 yrs | 66.7 yrs |
| % Female Patients | 55.7% | 48.3% |
| FDA Approval Date | Jun 20, 2023 | N/A |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Amgen Inc |
| Route | ORAL | INTRALESIONAL |
| Marketing Status | Discontinued | N/A |